Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sodium valproate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium valproate 150mg modified-release capsules
0408010W0AABQBQ
|
Sodium valproate | Sodium valproate | Central Nervous System | 1,148 |
|
Epilim Chronosphere MR 750mg granules sachets
0408010W0BBARBY
|
Epilim | Sodium valproate | Central Nervous System | 1,134 |
|
Sodium valproate 500mg MR gran sachets sugar free
0408010W0AABSBS
|
Sodium valproate | Sodium valproate | Central Nervous System | 855 |
|
Epilim Chronosphere MR 50mg granules sachets
0408010W0BBANBV
|
Epilim | Sodium valproate | Central Nervous System | 826 |
|
Sodium valproate 100mg MR gran sachets sugar free
0408010W0AABWBW
|
Sodium valproate | Sodium valproate | Central Nervous System | 581 |
|
Sodium valproate 1g modified-release gran sachets sugar free
0408010W0AABTBT
|
Sodium valproate | Sodium valproate | Central Nervous System | 445 |
|
Sodium valproate 250mg MR gran sachets sugar free
0408010W0AABXBX
|
Sodium valproate | Sodium valproate | Central Nervous System | 423 |
|
Epival CR 500mg tablets
0408010W0BHABA2
|
Epival (Epilepsy) | Sodium valproate | Central Nervous System | 346 |
|
Epival CR 300mg tablets
0408010W0BHAAA1
|
Epival (Epilepsy) | Sodium valproate | Central Nervous System | 295 |
|
Dyzantil 300mg modified-release tablets
0408010W0BKABA1
|
Dyzantil | Sodium valproate | Central Nervous System | 275 |
|
Dyzantil 500mg modified-release tablets
0408010W0BKACA2
|
Dyzantil | Sodium valproate | Central Nervous System | 269 |
|
Sodium valproate 750mg MR gran sachets sugar free
0408010W0AABYBY
|
Sodium valproate | Sodium valproate | Central Nervous System | 267 |
|
Sodium valproate 50mg MR gran sachets sugar free
0408010W0AABVBV
|
Sodium valproate | Sodium valproate | Central Nervous System | 204 |
|
Dyzantil 200mg modified-release tablets
0408010W0BKAAAZ
|
Dyzantil | Sodium valproate | Central Nervous System | 132 |
|
Sodium valproate 400mg/4ml solution for injection ampoules
0408010W0AABZBZ
|
Sodium valproate | Sodium valproate | Central Nervous System | 25 |
|
Sodium valproate 300mg/3ml solution for injection ampoules
0408010W0AABPBP
|
Sodium valproate | Sodium valproate | Central Nervous System | 21 |
|
Episenta 300mg/3ml solution for injection ampoules
0408010W0BIAABP
|
Episenta | Sodium valproate | Central Nervous System | 13 |
|
Sodium valproate 400mg inj vials
0408010W0AAAHAH
|
Sodium valproate | Sodium valproate | Central Nervous System | 5 |
|
Sodium valproate 300mg suppositories
0408010W0AABCBC
|
Sodium valproate | Sodium valproate | Central Nervous System | 4 |
|
Sodium valproate 500mg/5ml oral liquid
0408010W0AAA7A7
|
Sodium valproate | Sodium valproate | Central Nervous System | 4 |
|
Epilim Intravenous 400mg inj vials
0408010W0BBAIAH
|
Epilim | Sodium valproate | Central Nervous System | 3 |
|
Depakin 200mg/ml oral solution
0408010W0BJAACA
|
Depakin | Sodium valproate | Central Nervous System | 2 |
|
Orlept 500mg gastro-resistant tablets
0408010W0BEABAD
|
Orlept | Sodium valproate | Central Nervous System | 1 |
|
Orlept SF 200mg/5ml liquid
0408010W0BEACAA
|
Orlept | Sodium valproate | Central Nervous System | 1 |
|
Episenta 1g/10ml solution for injection ampoules
0408010W0BIAFBU
|
Episenta | Sodium valproate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.